EMAIL THIS PAGE TO A FRIEND

Eksperimental'naia i klinicheskaia farmakologiia

[The pharmacological effect of betapressin in hypertension].


PMID 9181866

Abstract

The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with essential decrease of peripheral vascular resistance. This circumstance, as well as acceleration of the heart rhythm, leads to increase of the cardiac output. Betapressin is recommended for monotherapy of patients suffering from stages I-II hypertension with eu- and hypokinetic types of hemodynamics.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

P0307000 Penbutolol sulfate, European Pharmacopoeia (EP) Reference Standard
C36H60N2O8S